A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates
- 31 May 2009
- journal article
- Published by Elsevier BV in Journal of Bioscience and Bioengineering
- Vol. 107 (5), 524-529
- https://doi.org/10.1016/j.jbiosc.2009.01.004
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oral adenoviral-based vaccines: historical perspective and future opportunityExpert Review of Vaccines, 2008
- Optimization of adenoviral production in human embryonic kidney cells using response surface methodologyJournal of Bioscience and Bioengineering, 2007
- Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of CancersHuman Gene Therapy, 2005
- Good Manufacturing Practice Production of Adenoviral Vectors for Clinical TrialsHuman Gene Therapy, 2005
- Adenoviruses as vaccine vectorsMolecular Therapy, 2004
- Development and optimization of an adenovirus production processThe Journal of Gene Medicine, 2004
- Adenoviral vectors for gene transfer and therapyThe Journal of Gene Medicine, 2004
- pH, pCO2, and Temperature Effect on R‐Adenovirus ProductionBiotechnology Progress, 2003
- Comparison of manufacturing techniques for adenovirus productionCytotechnology, 1999
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977